Device therapy with interatrial shunt devices for heart failure with preserved ejection fraction

Heart failure with preserved ejection fraction is responsible for half of all heart failure and confers substantial morbidity and mortality, and yet to date, there have been no effective pharmacologic interventions. Although the pathophysiology is complex, the primary aetiology of exercise intoleran...

Descripción completa

Detalles Bibliográficos
Autores principales: Nanayakkara, Shane, Kaye, David M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941219/
https://www.ncbi.nlm.nih.gov/pubmed/35438418
http://dx.doi.org/10.1007/s10741-022-10236-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941219/
https://www.ncbi.nlm.nih.gov/pubmed/35438418
http://dx.doi.org/10.1007/s10741-022-10236-8

Ejemplares similares